MP

Montila Pramanik

Director Director DIN 08142065
DIN 08142065 First appointment May 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2018
Shareholding value •••• Premium profile

About Montila Pramanik

Data last updated:

Montila Pramanik was a Director at Asprant Life Science Private Limited (2018–2022) and Designated Partner at Ableho Agencies Llp (2020–2022). The companies operate in Pharma and Transport and Logistics.

DIN 08142065
Primary Designation Director
Industry Pharma
First Appointment 24 May 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asprant Life Science Private Limited U24299WB2018PTC226270
Director24 May 20182018₹1.16 Cr (FY 2025)Active
Designated Partner14 Feb 20202020Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Asprant Life Science Private Limited
Ableho Agencies Llp
Premium access

Shareholding and investment profile for Montila Pramanik

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Montila Pramanik

Montila Pramanik was first appointed on 24 May 2018 as Director at Asprant Life Science Private Limited. The most recent appointment on record is 14 Feb 2020 at Ableho Agencies Llp.

Montila Pramanik held 2 earlier board appointments: Asprant Life Science Private Limited (Director, 24 May 2018 to 29 Jan 2022); Ableho Agencies Llp (Designated Partner, 14 Feb 2020 to 29 Jan 2022).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available